期刊文献+

淫羊藿苷经NF-κB信号通路干预大鼠免疫衰老的作用及机制 被引量:15

Study on the intervention of Icariin in immunosenescence via NF-κB signaling pathway
暂未订购
导出
摘要 目的探讨中药延缓免疫衰老的作用和机制。方法清洁级健康雄性SD大鼠50只,分为4月龄(4 mon)、24月龄(24 mon)、24月龄加PDTC处理(24 mon+PDTC)、24月龄加Ica(icariin,Ica)干预(24 m+Ica)和24月龄加Ica干预再加PDTC处理(24 mon+Ica+PDTC)五组,每组10只。自21月龄满开始,24 mon+Ica组和24 mon+Ica+PDTC组大鼠予Ica灌胃,24 mon组和24 mon+PDTC组给予等量蒸馏水灌胃,均连续3个月。24 mon+PDTC组和24 mon+Ica+PDTC组大鼠在灌胃结束前1 w每2 d腹腔注射PDTC,按200 mg/kg体重分2次注射。处死大鼠分别提取大鼠脾CD4+T淋巴细胞,用流式细胞仪检测细胞凋亡率,电泳迁移率(EMSA)检测细胞NF-κB的活性,Western印迹法检测细胞P65蛋白表达水平。结果 24 mon组大鼠脾CD4+T淋巴细胞凋亡率明显高于4 mon组和24 mon+PDTC组(P<0.05),而24 mon+Ica组细胞凋亡率显著降低(P<0.05);与24 mon+PDTC组比较,24 mon+Ica+PDTC组脾CD4+T淋巴细胞凋亡率明显降低(P<0.05)。与4 mon组大鼠相比,24 mon组大鼠脾CD4+T淋巴细胞中p65蛋白表达显著下调(P<0.01);与24 mon组比较,24 mon+Ica组p65蛋白表达明显上调(P<0.01),24 mon+PDTC组则显著下调(P<0.05)。与24 mon+PDTC组比较,24 mon+Ica+PDTC组p65蛋白表达明显增强(P<0.05)。24 mon组大鼠脾CD4+T淋巴细胞NF-κB的活性明显低于4 mon组(P<0.01);与24 mon组比较,24 mon+Ica组NF-κB的活性增强(P<0.01),24 mon+PDTC组NF-κB活性则降低(P<0.01)。相关分析表明,CD4+T淋巴细胞NF-κB活性与细胞凋亡率呈负相关(r=-0.75,P<0.01)。结论 NF-κB通过抑制淋巴细胞凋亡参与免疫衰老的调控;Ica可能通过提高NF-κB的活性和诱导P65高表达来抑制淋巴细胞过度凋亡从而延缓免疫衰老。 Objective To construct retrovirus vectors carrying IL-17 or siRNA-IL-17 genes with Thy1.1 gene and determine the infected ability of the retrovirus vectors to diabetogenic BDC2.5 T cells.Methods The IL-17 cDNA and thy1.1 full-length cDNA were subcloned into MIT(MSCV-IRES-Thy1.1) retrovirus vector,and the siRNA-IL-17,U6 promoter and Thy1.1 full-length cDNA were also inserted into retrovirus vector of pMND-BANSHEE.The recombined vectors transfected 293 packaging cells by DNA calcium phosphate coprecipitation.The virus supernatant which infected pre-activated spleen cells from NOD/BDC mice were collected.After incubation,the IL-17 expression in diabetogenic T cells was detected.Results By flow cytometry,retrovirus vectors carrying IL-17 or siRNA-IL-17 genes were constructed successfully.After infection of IL-17 or siRNA-IL-17 retrovirus to pre-activated primary NOD/BDC spleen T cells,the percentages of Thy1.1+/Thy1.2+ double positive cells were(0.6±0.3)%,(7.2±2.4)%,(6.8±2.6)%,(6.4±2.4)% and(4.6±1.8)% in Mock,MIT empty vector,Bcl-2 positive control,IL-17 p and siRNA-IL-17 vector groups,respectively.After the retrovirus with IL-17 infecting BDC2.5 T cells in vitro,the expression of IL-17 was significantly higher than that of siRNA-IL-17 group and control(both of P0.01).Infected IL-17 retrovirus to either non-activated or activated T cells respectively in vitro,the expression of IL-17 was distinctly higher than that of siRNA-IL-17 groups and control(both of P0.01).Moreover,the expression of IL-17 in the T cells activated groups was higher than that of non-activated T cells groups(P0.01).On the other hand,the expression of IL-17 was markedly reduced in the groups of infection siRNA-IL-17,and no difference to the control(both of P0.01).Conclusions The IL-17 expression of IL-17 diabetogenic BDC2.5 T cells in vitro is higher than that of the transgenic cells of siRNA-IL-17.It is concluded the retrovirus vectors can be used as am important tool to transfer a foreign gene into T cells efficiently.
出处 《中国老年学杂志》 CAS CSCD 北大核心 2010年第20期2938-2941,共4页 Chinese Journal of Gerontology
基金 中国博士后科学基金(No.20060400578) 上海市科委科研计划项目(No.10JC1404800 No.09410705800)
关键词 免疫衰老 核因子-ΚB CD4+T淋巴细胞 凋亡 淫羊藿苷 Retrovirus vector IL-17 gene T cells NOD mouse
  • 相关文献

参考文献15

  • 1Miller RA.The aging immune system:primer and prospectus[J].Science,1996;(5):71-3.
  • 2Karin M,Cao Y,Greten FR,et al.NF-κB in cancer:from innocent by stander to major culprit[J].Nat Rev Drug Discov,2002;2:301-10.
  • 3Shishodia S,Aggarwal BB.Nuclear factor-kappaB:a friend or a foe in cancer[J]? Biochem Pharmacol,2004;68:1071-80.
  • 4刘小雨,夏韵,王琦,吴斌,黄建华,夏世金,陈伟华,沈自尹.增龄进程淋巴细胞NF-κB信号通路胞外配体mRNA差异表达特征及淫羊藿总黄酮的干预效应[J].中国免疫学杂志,2008,24(9):808-809. 被引量:2
  • 5夏世金,沈自尹,刘小雨,黄建华,吴斌.核因子-κB调控老年大鼠脾淋巴细胞凋亡及淫羊藿总黄酮对其影响[J].中国老年学杂志,2008,28(2):105-108. 被引量:15
  • 6Bruunsgaard H.The clinical impact of systemic low-level inflammation in elderly populations.With special reference to cardiovascular disease,dementia and mortality[J].Dan Med Bull,2006;53:285-309.
  • 7Larbi A,Franceschi C,Mazzatti D,et al.Aging of the immune system as a prognostic factor for human longevity[J].Physiology (Bethesda),2008;23:64-74.
  • 8Licastro F,Candore G,Lio D,et al.Innate immunity and inflammation in ageing:a key for understanding age-related diseases[J].Immun Ageing,2005;2:8.
  • 9Onnappan U,Zhong M,Trebilcock GU.Decreased proteasome-mediated degradation in T cells from the elderly:a role in immune senescence[J].Cell Immunol,1999;192:167-74.
  • 10Trebilcock G.U,Ponnappan U.Evidence for lowered induction of nuclear factor κB in activated human T lymphocytes during aging[J].Gerontology,1996;42:137-46.

二级参考文献12

  • 1刘小雨,沈自尹,黄建华,陈伟华.淫羊藿总黄酮经由核因子-κB相关信号转导途径调控免疫衰老机制[J].中国中西医结合杂志,2006,26(7):620-624. 被引量:26
  • 2刘小雨,夏世金,沈自尹.衰老进程中核转录因子-κB表达的变化[J].中华老年医学杂志,2007,26(9):713-716. 被引量:6
  • 3Miller RA. The aging immune system: primer and prospectus [J]. Science,1996; (5) :71-3.
  • 4Karin M, Cao Y, Greten FR, et al. NF-kB in cancer: from innocent by stander to major culprit[J]. Nat Rev Cancer,2002 ;2(4) :301-10.
  • 5Shishodia S, Aggarwal BB. Nuclear factor-kappaB : a friend or a foe in cancer [J] ? Biochem Pharmacol, 2004 ; 68 ( 6 ) : 1071-80.
  • 6Sen R, Baltimore D. Mutiple nuclear factors interact with the immunoglobulin enhancer sequence[ J ]. Cell, 1986 ;46( 5 ) :705-16.
  • 7Morkve O, Laerum OD. Flow cytometric measurement of p53 protein expression and DNA content in paraffin embedded tissue from bronchial carcinomas [J]. Cytometry, 1991; 12 ( 5 ) :438-41.
  • 8Ponnappan U, Zhong M, Trebilcock GU. Decreased proteasome-mediated degradation in T cells from the elderly:a role in immune senescence [J]. Cell Immunol, 1999 ; 192 (2) : 167-74.
  • 9Vermeulen L, De Wilde G, Van Damme P,et al. Transcriptional activation of the NF-KB P65 subunit by mitogen-and stress-activated protein kinase- 1 ( MSK1 ) [J]. EMBO J,2003 ;6(22 ) : 1313-24.
  • 10Farhana L, Dawson MI, Fontana JA. Apoptosis induction by a novel retinoid-related molecule requires nuclear factor-KB activation [J]. Cancer Res,2005 ;65( 11 ) :4909-17.

共引文献14

同被引文献245

引证文献15

二级引证文献168

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部